TerminatedPhase 2

Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster Keratitis

Stopped: There were difficulties meeting the enrollment goal within stipulated time frames.

United States8 participantsStarted 2013-12-10

Plain-language summary

The purpose of this study is to evaluate the efficiency of topical gancyclovir 0.15% in the treatment of herpes zoster keratitis. Half the patients will receive the study drug while the other half of the patients will receive the placebo

Who can participate

Age range18 Years – 95 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age 18 and above * have not been on gancyclovir gel or any other form of topical antiviral therapy for the past month * able and willing to attend subsequent follow-up visits Exclusion Criteria: * Associated retinitis * patients who are allergic to gancyclovir * patients who will require systemic or intra-vitreal gancyclovir therapy * patients who are pregnant or breastfeeding

What they're measuring

Corneal Ulcer Healing

Timeframe: 2 weeks

Trial details

NCT IDNCT02382588

SponsorNorthwestern University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-05-11

Results submitted2021-03-29

View on ClinicalTrials.gov More Herpes Zoster Keratitis trials